Altimmune (ALT) Stock: Rocketing On Clinical Data

Altimmune ALT Stock News

Altimmune Inc (NASDAQ: ALT) is flying in the market today, and for good reason. The company announced positive clinical data surrounding a flu vaccine. As you could imagine, the news proved to be exciting for investors. Today, we’ll talk about: The data; what we’re seeing from the stock; and what we’ll be watching for ahead.  … Read more